Dieter MOOSMAYER

Person

Berlin, DE

People

Patents Grantslast 30 patents

Information Patent Grant
2-(morpholin-4-yl)-1,7-naphthyridines
- Patent number 11,529,356
- Issue date Dec 20, 2022
- Bayer Pharma Aktiengesellschaft
- Lars Wortmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4H-pyrrolo[3,2-c]pyridin-4-one derivatives
- Patent number 11,339,157
- Issue date May 24, 2022
- Bayer Aktiengesellschaft
- Stephan Siegel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-(morpholin-4-yl)-1,7-naphthyridines
- Patent number 10,772,893
- Issue date Sep 15, 2020
- Bayer Pharma Aktiengesellschaft
- Lars Wortmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-...
- Patent number 10,722,501
- Issue date Jul 28, 2020
- Bayer Aktiengesellschaft
- Nicole Biber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-(morpholin-4-yl)-1,7-naphthyridines
- Patent number 9,993,484
- Issue date Jun 12, 2018
- Bayer Pharma Aktiengesellschaft
- Lars Wortmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Site-specific antibody-mediated activation of proapoptotic cytokine...
- Patent number 9,944,708
- Issue date Apr 17, 2018
- BioNTech AG
- Klaus Pfizenmaier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-(morpholin-4-yl)-1,7-naphthyridines
- Patent number 9,549,932
- Issue date Jan 24, 2017
- Bayer Pharma Aktiengesellschaft
- Lars Wortmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Site-specific antibody-mediated activation of proapoptotic cytokine...
- Patent number 8,980,265
- Issue date Mar 17, 2015
- BioNTech AG
- Klaus Pfizenmaier
- B82 - NANO-TECHNOLOGY

Patents Applicationslast 30 patents

Information Patent Application
2-Methyl-Quinazolines
- Publication number 20240083857
- Publication date Mar 14, 2024
- BAYER PHARMA AKTIENGESELLSCHAFT
- Lars WORTMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-METHYL-AZA-QUINAZOLINES
- Publication number 20220274979
- Publication date Sep 1, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Lars WORTMANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-METHYL-QUINAZOLINES
- Publication number 20220235013
- Publication date Jul 28, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Lars WORTMANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IDENTIFICATION AND USE OF KRAS INHIBITORS
- Publication number 20220227729
- Publication date Jul 21, 2022
- Bayer Aktiengesellschaft
- Duy NGUYEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)
- Publication number 20220041752
- Publication date Feb 10, 2022
- Bayer HealthCare LLC
- Zhuozhi Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES
- Publication number 20200383991
- Publication date Dec 10, 2020
- BAYER PHARMA AKTIENGESELLSCHAFT
- Lars Wortmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)
- Publication number 20190194353
- Publication date Jun 27, 2019
- Bayer HealthCare LLC
- Zhuozhi Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRIDINE-3(2H)-...
- Publication number 20190160048
- Publication date May 30, 2019
- Bayer Aktiengesellschaft
- Nicole BIBER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES
- Publication number 20180256591
- Publication date Sep 13, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Lars Wortmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)
- Publication number 20180194857
- Publication date Jul 12, 2018
- Bayer HealthCare LLC
- Zhuozhi Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES
- Publication number 20170216304
- Publication date Aug 3, 2017
- BAYER PHARMA AKTIENGESELLSCHAFT
- Lars Wortmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)
- Publication number 20170107298
- Publication date Apr 20, 2017
- Bayer HealthCare LLC
- Zhuozhi WANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES
- Publication number 20160287604
- Publication date Oct 6, 2016
- BAYER PHARMA AKTIENGESELLSCHAFT
- Lars Wortmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SITE-SPECIFIC ANTIBODY-MEDIATED ACTIVATION OF PROAPOPTOTIC CYTOKINE...
- Publication number 20150152186
- Publication date Jun 4, 2015
- BIONTECH AG
- Klaus Pfizenmaier
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)
- Publication number 20140294832
- Publication date Oct 2, 2014
- Bayer HealthCare LLC
- Zhuozhi Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fusion protein from antibody cytokine-cytokine inhibitor (selectoki...
- Publication number 20040053829
- Publication date Mar 18, 2004
- Klaus Pfizenmaier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Site-specific antibody-mediated activation of proapoptotic cytokine...
- Publication number 20040033511
- Publication date Feb 19, 2004
- Klaus Pfizenmaier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for diagnosis and treatment of tumours
- Publication number 20040001790
- Publication date Jan 1, 2004
- Schering AG
- Christoph-Stephan Hilger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human FAP-alpha-specific antibodies
- Publication number 20020099180
- Publication date Jul 25, 2002
- Klaus Pfizenmaier
- C07 - ORGANIC CHEMISTRY

Dieter MOOSMAYER

Person

Patents Grantslast 30 patents

2-(morpholin-4-yl)-1,7-naphthyridines

4H-pyrrolo[3,2-c]pyridin-4-one derivatives

2-(morpholin-4-yl)-1,7-naphthyridines

Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-...

2-(morpholin-4-yl)-1,7-naphthyridines

Site-specific antibody-mediated activation of proapoptotic cytokine...

2-(morpholin-4-yl)-1,7-naphthyridines

Site-specific antibody-mediated activation of proapoptotic cytokine...

Patents Applicationslast 30 patents

2-Methyl-Quinazolines

2-METHYL-AZA-QUINAZOLINES

2-METHYL-QUINAZOLINES

IDENTIFICATION AND USE OF KRAS INHIBITORS

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

SUBSTITUTED 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRIDINE-3(2H)-...

2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES

SITE-SPECIFIC ANTIBODY-MEDIATED ACTIVATION OF PROAPOPTOTIC CYTOKINE...

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

Fusion protein from antibody cytokine-cytokine inhibitor (selectoki...

Site-specific antibody-mediated activation of proapoptotic cytokine...

Methods for diagnosis and treatment of tumours

Human FAP-alpha-specific antibodies